M. Savontaus et al., EXPRESSION OF TYPE-II AND TYPE-IX COLLAGEN ISOFORMS DURING NORMAL ANDPATHOLOGICAL CARTILAGE AND EYE DEVELOPMENT, HISTOCHEM C, 110(2), 1998, pp. 149-159
Cartilage collagens type II and type IX exist in two alternative forms
which arise from alternative splicing and alternative use of promoter
s, respectively In the present study we analyzed temporal and spatial
expression patterns of the two isoforms of type II and type IX collage
n transcripts as well as those of alpha 2(IX) and alpha 3(IX) collagen
mRNAs in limb cartilages and eyes during mouse embryonic development.
Northern and RNase protection assays revealed temporal coregulation o
f the two alternative isoforms in limbs, but not in the eye where no l
ong form of alpha 1(IX) collagen mRNA was detected. Although in situ h
ybridization of limbs revealed identical expression patterns of the lo
ng form of type II collagen and the short form of alpha 1(IX) collagen
mRNA in the perichondrium and periosteum of 14.5-18.5-day embryos, th
e patterns were distinctly different at day 12.5 of development: the l
ong form of type II collagen mRNA was expressed throughout the develop
ing cartilaginous anlage whereas the short form of alpha 1(TX) collage
n mRNA was expressed in the surrounding mesenchyme. Some differences w
ere also detected in the temporal and spatial expression patterns betw
een the alpha 1(IX), alpha 2(IX), and alpha 3(IX) collagen mRNAs. In t
he eyes, alpha 2(IX) collagen mRNA had highest expression levels at da
y 12.5, whereas alpha 1(IX) and a3(IX) collagen mRNAs peaked later, at
day 16.5. In the limbs, alpha 1(IX) and alpha 3(IX), but not alpha 2(
IX), collagen mRNAs were detected in periosteal cells after 16.5 days
of development. In transgenic Del1 mice, harboring type II collagen tr
ansgenes with a small deletion mutation, expression of mutant mRNA aff
ected neither the alternative splicing of wild-type or mutant transcri
pts nor the ratio of the two alternative forms of the alpha 1(IX) coll
agen mRNA. Despite some distinct similarities, the two alternative for
ms of type II and type IX collagen must, therefore, be under different
ial control during mouse development.